Cargando…
Toxoplasma gondii exposure and Parkinson's disease: a case–control study
OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and contr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318570/ https://www.ncbi.nlm.nih.gov/pubmed/28193849 http://dx.doi.org/10.1136/bmjopen-2016-013019 |
_version_ | 1782509217813364736 |
---|---|
author | Alvarado-Esquivel, Cosme Méndez-Hernández, Edna Madai Salas-Pacheco, José Manuel Ruano-Calderón, Luis Ángel Hernández-Tinoco, Jesús Arias-Carrión, Oscar Sánchez-Anguiano, Luis Francisco Castellanos-Juárez, Francisco Xavier Sandoval-Carrillo, Ada Agustina Liesenfeld, Oliver Ramos-Nevárez, Agar |
author_facet | Alvarado-Esquivel, Cosme Méndez-Hernández, Edna Madai Salas-Pacheco, José Manuel Ruano-Calderón, Luis Ángel Hernández-Tinoco, Jesús Arias-Carrión, Oscar Sánchez-Anguiano, Luis Francisco Castellanos-Juárez, Francisco Xavier Sandoval-Carrillo, Ada Agustina Liesenfeld, Oliver Ramos-Nevárez, Agar |
author_sort | Alvarado-Esquivel, Cosme |
collection | PubMed |
description | OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and controls were enrolled in Durango City, Mexico. PARTICIPANTS: 65 patients with Parkinson's disease and 195 age- and gender-matched control subjects without Parkinson's disease. PRIMARY AND SECONDARY OUTCOME MEASURES: Serum samples of participants were analysed for anti-T. gondii IgG and IgM antibodies by commercially available enzyme-linked immunoassays. Prevalence of T. gondii DNA was determined in seropositive subjects using PCR. The association between clinical data and infection was examined by bivariate analysis. RESULTS: Anti-T. gondii IgG antibodies were found in 6/65 cases (9.2%) and in 21/195 controls (10.8%) (OR 0.84; 95% CI 0.32 to 2.18; p=0.81). The frequency of high (>150 IU/mL) antibody levels was similar among cases and controls (p=0.34). None of the anti-T. gondii IgG positive cases and four of the anti-T. gondii IgG positive controls had anti-T. gondii IgM antibodies (p=0.54). The prevalence of T. gondii DNA was comparable in seropositive cases and controls (16.7% and 25%, respectively; p=1.0). Seroprevalence of T. gondii infection was associated with a young age onset of disease (p=0.03), high Unified Parkinson Disease Rating Scale scores (p=0.04) and depression (p=0.02). Seropositivity to T. gondii infection was lower in patients treated with pramipexole than in patients without this treatment (p=0.01). However, none of the associations remained significant after Bonferroni correction. CONCLUSIONS: The results do not support an association between T. gondii infection and Parkinson's disease. However, T. gondii infection might have an influence on certain symptoms of Parkinson's disease. Further research to elucidate the role of T. gondii exposure on Parkinson's disease is warranted. |
format | Online Article Text |
id | pubmed-5318570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53185702017-02-27 Toxoplasma gondii exposure and Parkinson's disease: a case–control study Alvarado-Esquivel, Cosme Méndez-Hernández, Edna Madai Salas-Pacheco, José Manuel Ruano-Calderón, Luis Ángel Hernández-Tinoco, Jesús Arias-Carrión, Oscar Sánchez-Anguiano, Luis Francisco Castellanos-Juárez, Francisco Xavier Sandoval-Carrillo, Ada Agustina Liesenfeld, Oliver Ramos-Nevárez, Agar BMJ Open Infectious Diseases OBJECTIVES: To determine the association between Toxoplasma gondii infection and Parkinson's disease and to investigate whether T. gondii seropositivity is associated with the general characteristics of patients with Parkinson's disease. DESIGN: Case–control study. SETTING: Cases and controls were enrolled in Durango City, Mexico. PARTICIPANTS: 65 patients with Parkinson's disease and 195 age- and gender-matched control subjects without Parkinson's disease. PRIMARY AND SECONDARY OUTCOME MEASURES: Serum samples of participants were analysed for anti-T. gondii IgG and IgM antibodies by commercially available enzyme-linked immunoassays. Prevalence of T. gondii DNA was determined in seropositive subjects using PCR. The association between clinical data and infection was examined by bivariate analysis. RESULTS: Anti-T. gondii IgG antibodies were found in 6/65 cases (9.2%) and in 21/195 controls (10.8%) (OR 0.84; 95% CI 0.32 to 2.18; p=0.81). The frequency of high (>150 IU/mL) antibody levels was similar among cases and controls (p=0.34). None of the anti-T. gondii IgG positive cases and four of the anti-T. gondii IgG positive controls had anti-T. gondii IgM antibodies (p=0.54). The prevalence of T. gondii DNA was comparable in seropositive cases and controls (16.7% and 25%, respectively; p=1.0). Seroprevalence of T. gondii infection was associated with a young age onset of disease (p=0.03), high Unified Parkinson Disease Rating Scale scores (p=0.04) and depression (p=0.02). Seropositivity to T. gondii infection was lower in patients treated with pramipexole than in patients without this treatment (p=0.01). However, none of the associations remained significant after Bonferroni correction. CONCLUSIONS: The results do not support an association between T. gondii infection and Parkinson's disease. However, T. gondii infection might have an influence on certain symptoms of Parkinson's disease. Further research to elucidate the role of T. gondii exposure on Parkinson's disease is warranted. BMJ Publishing Group 2017-02-13 /pmc/articles/PMC5318570/ /pubmed/28193849 http://dx.doi.org/10.1136/bmjopen-2016-013019 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Infectious Diseases Alvarado-Esquivel, Cosme Méndez-Hernández, Edna Madai Salas-Pacheco, José Manuel Ruano-Calderón, Luis Ángel Hernández-Tinoco, Jesús Arias-Carrión, Oscar Sánchez-Anguiano, Luis Francisco Castellanos-Juárez, Francisco Xavier Sandoval-Carrillo, Ada Agustina Liesenfeld, Oliver Ramos-Nevárez, Agar Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title | Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title_full | Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title_fullStr | Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title_full_unstemmed | Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title_short | Toxoplasma gondii exposure and Parkinson's disease: a case–control study |
title_sort | toxoplasma gondii exposure and parkinson's disease: a case–control study |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318570/ https://www.ncbi.nlm.nih.gov/pubmed/28193849 http://dx.doi.org/10.1136/bmjopen-2016-013019 |
work_keys_str_mv | AT alvaradoesquivelcosme toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT mendezhernandezednamadai toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT salaspachecojosemanuel toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT ruanocalderonluisangel toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT hernandeztinocojesus toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT ariascarrionoscar toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT sanchezanguianoluisfrancisco toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT castellanosjuarezfranciscoxavier toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT sandovalcarrilloadaagustina toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT liesenfeldoliver toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy AT ramosnevarezagar toxoplasmagondiiexposureandparkinsonsdiseaseacasecontrolstudy |